Virtu KCG Holdings’s Apollo Endosurgery, Inc. APEN Stock Holding History

Virtu KCG Holdings’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-403	Closed	-$6K	–	3438
2016 Q1	$6K	Buy	403 +172	+74%	+$2.39K	﹤0.01%	2674
2015 Q4	$4K	Sell	231 -1,700	-88%	-$28.6K	﹤0.01%	3415
2015 Q3	$28K	Buy	1,931 +311	+19%	+$5.92K	﹤0.01%	3107
2015 Q2	$34K	Buy	1,620 +1,031	+175%	+$102K	﹤0.01%	3131
2015 Q1	$112K	Buy	589 +353	+150%	+$81.1K	﹤0.01%	2625
2014 Q4	$51K	Buy	+236	New	+$52.7K	﹤0.01%	3431
2014 Q1	–	Sell	-266	Closed	-$87K	–	4219
2013 Q4	$87K	Buy	+266	New	+$97.7K	﹤0.01%	3479

Other funds holding APEN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SBIA

Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Virtu KCG Holdings's APEN Position: Q2 2016 in Review

Virtu KCG Holdings sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2016, closing a stake of 403 shares — an estimated $6K sold.

Virtu KCG Holdings first reported a position in APEN in Q4 2013 and held it in 7 quarters. The position peaked at $112K in Q1 2015. 11 funds tracked by Wall St. Rank hold APEN as of Q2 2016.

Virtu KCG Holdings reported no remaining Apollo Endosurgery, Inc. position as of Q2 2016 after selling out during the quarter.
Virtu KCG Holdings sold 403 Apollo Endosurgery, Inc. shares in Q2 2016, an estimated $6K.
Virtu KCG Holdings first reported a position in Apollo Endosurgery, Inc. in Q4 2013 and held it in 7 quarters.
Virtu KCG Holdings's Apollo Endosurgery, Inc. position peaked at $112K in Q1 2015.
11 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2016.

Based on Virtu KCG Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.